MOSAIQ Oncology System (Elekta) – Image Offset Risk (2025)
Hazard assessment based on recall description.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
MOSAIQ Oncology Information System
Brand
Elekta, Inc.
Lot Codes / Batch Numbers
Software versions /UDI: 3.1.2.0 (01)07340201500026 3.1.3.0 (01)07340201500026, 3.1.3.1 (01)07340201500026, 3.1.3.2 (01)07340201500026, 3.1.3.3 (01)07340201500026, 3.1.3.4 (01)07340201500026, 3.2.1.0 (01)07340201500071, 3.2.1.1 (01)07340201500071, 3.2.1.2 (01)07340201500071, 3.2.1.3 (01)07340201500071, 3.2.1.4 (01)07340201500071
Products Sold
Software versions /UDI: 3.1.2.0 (01)07340201500026 3.1.3.0 (01)07340201500026; 3.1.3.1 (01)07340201500026; 3.1.3.2 (01)07340201500026; 3.1.3.3 (01)07340201500026; 3.1.3.4 (01)07340201500026; 3.2.1.0 (01)07340201500071; 3.2.1.1 (01)07340201500071; 3.2.1.2 (01)07340201500071; 3.2.1.3 (01)07340201500071; 3.2.1.4 (01)07340201500071
Elekta, Inc. is recalling MOSAIQ Oncology Information System due to Image offsets calculated by oncology Information System software may be incorrect for Linear Accelerator (LINACs) not characterized at IEC61217 scal. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Image offsets calculated by oncology Information System software may be incorrect for Linear Accelerator (LINACs) not characterized at IEC61217 scale.
Recommended Action
Per FDA guidance
On January 15, 2025 Elekta issued a recall notification to affected consignees via Email. Elekta asked consignees to take the following actions. 1. Customers included in the scope of the Field Safety Notice, should not calculate shifts from 2D verification images taken at a non-zero patient support angle (couch angle). 2. Please post this notice in a place accessible to all users, e.g. Instructions for Use, until this action is closed. 3. Advise the appropriate personnel, working with this product, on the content of this letter. 4. You are required to either acknowledge receipt of this notification via the Elekta Care" Community or complete this form and return it to Elekta immediately upon receipt, but no later than within 30 days.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
AL, FL, IA, PA, UT
Page updated: Jan 10, 2026